Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; triethyl citrate; pregelatinised maize starch; purified talc; hypromellose; colloidal anhydrous silica; titanium dioxide; ammonia; magnesium stearate; methacrylic acid copolymer; povidone; iron oxide red - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: colloidal anhydrous silica; pregelatinised maize starch; povidone; magnesium stearate; iron oxide red; methacrylic acid copolymer; triethyl citrate; microcrystalline cellulose; titanium dioxide; ammonia; purified talc; hypromellose - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - mesalazine 1 g;  ; mesalazine 1 g - modified release granules - 1 g - active: mesalazine 1 g   excipient: acetone ethylcellulose microcrystalline cellulose purified water active: mesalazine 1 g excipient: acetone ethylcellulose povidone purified water - treatment of mild to moderate ulcerative colitis

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - mesalazine 2 g;  ; mesalazine 2 g - modified release granules - 2 g - active: mesalazine 2 g   excipient: ethylcellulose microcrystalline cellulose active: mesalazine 2 g excipient: ethylcellulose povidone - treatment of mild to moderate ulcerative colitis

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - mesalazine - enema - mesalazine 1 g / 100 ml - aminosalicylic acid and similar agents - ulcerative colitis - chron's disease

Australia - English - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - mesalazine, quantity: 1 g - foam - excipient ingredients: propane; cetostearyl alcohol; disodium edetate; propylene glycol; butane; polysorbate 60; isobutane; sodium metabisulfite - salofalk foam enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

Malta - English - Medicines Authority

faes farma s.a. maximo aguirre 14, leioa bizkaia 48940, spain - mesalazine - suppository - mesalazine 1 g - antidiarrheals, intestinal antiinflammatory/antiinfective agents

Malta - English - Medicines Authority

faes farma s.a. maximo aguirre 14, leioa bizkaia 48940, spain - mesalazine - suppository - mesalazine 500 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - mesalazine, quantity: 1000 mg - suppository, compressed - excipient ingredients: purified talc; povidone; macrogol 6000; magnesium stearate - treatment of ulcerative procitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - mesalazine, quantity: 1000 mg - enema - excipient ingredients: disodium edetate; sodium acetate; purified water; sodium metabisulfite; hydrochloric acid - for the treatment of ulcerative proctosigmoiditis and/or treatment of left-sided ulcerative colitis.